Nosocomial Acinetobacter pneumonia

被引:48
|
作者
Luna, Carlos M. [1 ]
Aruj, Patricia K. [1 ]
机构
[1] Univ Buenos Aires, Hosp Clin, Dept Internal Med, Div Pulm Dis, Buenos Aires, DF, Argentina
关键词
Acinetobacter; nosocomial pneumonia; multi-drug resistant; ventilator-associated pneumonia;
D O I
10.1111/j.1440-1843.2007.01147.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Acinetobacter spp. (A. baumannii is the prevalent genomic species, but others may cause infection) has become an increasingly important cause of nosocomial pneumonia, particularly in mechanically ventilated patients (VAP). This organism has intrinsic resistance to some antimicrobials but easily acquires resistance to many others; Acinetobacter spp. can survive for long periods of time in the environment. All of these characteristics have contributed to protracted outbreaks associated with significant morbidity and mortality. High rates of colonization are found in debilitated hospitalized patients. Infecting or colonizing organisms in nosocomial infections are more likely to be from cross-transmission or from the hospital environment than from endogenous sources. VAP caused by Acinetobacter spp. is emerging as a prominent hospital complication. The incidence of this microorganism varies from site to site, but it is the second commonest aetiological agent among the gram-negative bacteria. Longer periods of hospitalization, longer time on mechanical ventilation and prior use of antibiotics are the recognized factors increasing the risk of VAP due to Acinetobacter spp. Treatment needs to clearly differentiate infection from colonization, and the agents with the most antimicrobial activity are imipenem/cilastatin, amikacin, colistin, ampicillin/sulbactam and tigecycline. Monotherapy can be adequate if the patient does not have significant comorbidities. Infection control procedures have a major role to play in preventing transmission of this microorganism. Emphasis on initial control measures should, however, be on strict isolation of infected or colonized patients to limit dissemination of outbreak strains in the environment. The variety of potential sources of contamination with Acinetobacter spp. in the hospital environment makes control of these outbreaks one of the more difficult challenges. Persistence of Acinetobacter spp. in the environment provides ample opportunities for contamination of patients and staff and may explain continuing long-term outbreaks.
引用
收藏
页码:787 / 791
页数:5
相关论文
共 50 条
  • [1] Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases
    Ozvatan, Tulay
    Akalin, Halis
    Sinirtas, Melda
    Ocakoglu, Gokhan
    Yilmaz, Emel
    Heper, Yasemin
    Kelebek, Nermin
    Iscimen, Remzi
    Kahveci, Ferda
    RESPIROLOGY, 2016, 21 (02) : 363 - 369
  • [2] Nosocomial pneumonia due to Acinetobacter baumanii in the Intensive Care Unit
    Jurdak, Hady
    Moghnieh, Rima
    Lababidi, Hani M.
    CHEST, 2006, 130 (04) : 262S - 262S
  • [3] Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
    Tuna Demirdal
    Ummu Sena Sari
    Salih Atakan Nemli
    Annals of Clinical Microbiology and Antimicrobials, 15
  • [4] Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
    Demirdal, Tuna
    Sari, Ummu Sena
    Nemli, Salih Atakan
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2016, 15
  • [5] Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia
    Baraibar, J
    Correa, H
    Mariscal, D
    Gallego, M
    Valles, J
    Rello, J
    CHEST, 1997, 112 (04) : 1050 - 1054
  • [6] Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin
    Motaouakkil, S
    Charra, B
    Hachimi, A
    Benslama, A
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2006, 25 (05): : 543 - 544
  • [7] Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?
    Lee, Y. -T.
    Kuo, S. -C.
    Yang, S. -P.
    Lin, Y. -T.
    Chiang, D. -H.
    Tseng, F. -C.
    Chen, T-L.
    Fung, C. -P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (07) : 640 - 645
  • [8] Homology Analysis and Nosocomial Infection Control on Outbreak of ICU Acinetobacter baumannii Pneumonia
    Gao, Jianping
    Ying, Kejing
    CHEST, 2016, 149 (04) : 93A - 93A
  • [9] A DECADE OF NOSOCOMIAL ACINETOBACTER
    LARSON, E
    AMERICAN JOURNAL OF INFECTION CONTROL, 1984, 12 (01) : 14 - 18
  • [10] Nosocomial Acinetobacter meningitis
    Kralinsky, K
    Krcmeryova, T
    Tuharsky, J
    Krcmery, V
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) : 270 - 271